Osteoarthritis (OA) presents itself in 4 different grades or stages, and by discovering the stage of your condition we can help determine the severity and the required treatment…

During your consultation at Macquarie Stem Cells we will determine the stage of your osteoarthritis and will discuss stem cell therapy treatment for you. Our unique stem cell therapy is becoming increasingly popular for sufferers of this condition. While there is no cure for osteoarthritis our stem cell therapy procedure can work to decrease pain and improve your quality of life by prompting the regeneration process in the affected area.

What are grades and why are they important? 

The stages of osteoarthritis are important for both the patient’s awareness and our team’s ability to assess and treat their needs. By first determining the scale of your condition we can then find the appropriate solution. The stages of osteoarthritis are measured in four levels, one being the least severe and four being the most.

The four grades and their symptoms  

Osteoarthritis is a condition that causes the cartilage in your joints to break down, with less cartilage your bones cannot move as freely.

shutterstock_94626562

 

Stage 1: This is the most minor stage of OA, patients will show very minor bone spur growth. Usually, patients with Stage 1 OA do not experience any pain or discomfort as a result of the very minor wear on the components of the joint, if this treatment is found early however it can be treated with stem cell therapy to help encourage cartilage growth.

Stage 2: This is usually the stage where patients begin to experience symptoms. Commonly they will feel pain after a day of walking or running, greater stiffness in the joint when it’s not used for several hours and tenderness when kneeling or bending.

Stage 3: At this stage the cartilage between the bones shows obvious damage, and the space between the bones narrows, this stage is known as ‘moderate osteoarthritis’.

Stage 4: This is the most severe stage of OA, if you are in this stage you will experience significant discomfort when walking or moving the affected joint.

Have your osteoarthritis treated by Macquarie Stem Cells

For best results we treat osteoarthritis patients who are suffering from stage 1-3, however we can still use our stem cell therapy to treat patients suffering from stage four OA. Before you visit our Sydney office you can get a better understanding of how severe your osteoarthritis is with our online WOMAC and HOOS assessments. With WOMAC targeted at grading knee osteoarthritis and HOOS targeted at hip osteoarthritis you can get a more detailed understanding of your condition.

Download HOOS

Download WOMAC

During your consultation at Macquarie Stem Cells we will discuss your pain caused from osteoarthritis and your problems with function and quality of life, to get a better understanding of the stage of your condition. Through our innovative stem cell therapy, we can help decrease pain and improve movement in your joints.

How can stem cell therapy help my osteoarthritis?

Stem cell therapy is becoming increasingly popular among OA patients because it doesn’t require you to take a long list of medication or involve serious surgery.  The stem cell procedure involves retrieving cells from adipose (fat) tissue with our ultrasonic cavitation technique, which is minimally invasive. These treated cells are then injected into the affected joint. This treatment can help rehabilitate connective tissue and cartilage which has been lost due to osteoarthritis of the knee, hip or spine.

For more information about osteoarthritis or to book a consultation please don’t hesitate to contact us.  Fill in your details to request a call back or call us: 02 8103 4298

References

Michalek J, et al, Autologous adipose tissue-derived stromal vascular fraction cells application in patients with osteoarthritis. Cell Transplant. 2015 Jan 20. doi: 10.3727/096368915X686760

Riordan et al, Autologous Stromal Vascular Fraction Cells: A Tool for Facilitating Tolerance in Rheumatic Disease, DOI. 10.1016/j.cellimm.2010.04.002